Skip to main content

Peer Review reports

From: A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9–11 year-old girls and boys – clinical protocol

Original Submission
2 Feb 2019 Submitted Original manuscript
26 Feb 2019 Author responded Author comments - Yi Zeng
Resubmission - Version 2
26 Feb 2019 Submitted Manuscript version 2
Publishing
7 Mar 2019 Editorially accepted
1 Apr 2019 Article published 10.1186/s12885-019-5444-4

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us